Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
Business Wire•01/10/2026•08:00 ET
0
Key Highlights
- ➤VTAMA analysis will assess real-world effectiveness in atopic dermatitis patients
- ➤2026 Fall Clinical Dermatology Conference presentation planned for Las Vegas
- ➤Analysis measures BSA, PGA, and patient-reported itch-score improvements
- ➤VTAMA indicated for plaque psoriasis in adults
- ➤VTAMA indicated for atopic dermatitis in adults and pediatric patients 2+
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
New data will represent one of the first large-scale real-world effectiveness analyses of VTAMA cream in patients with atopic dermatitis (AD)
Get started
Create a free account to read the full story.